Pomalidomide With Low-Dose Dexamethasone New Treatment Option for Multiple Myeloma

Pomalidomide, an immunomodulatory drug, combined with low-dose dexamethasone improved progression-free survival in patients with refractory or relapsed and refractory multiple myeloma compared with standard of care high-dose dexamethasone, according to a new study.
Source: Cancer Network - Category: Cancer & Oncology Source Type: news